Victory Capital Management’s iTeos Therapeutics ITOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-102,188
Closed -$610K 2512
2025
Q1
$610K Buy
102,188
+429
+0.4% +$2.56K ﹤0.01% 1976
2024
Q4
$782K Buy
101,759
+6,519
+7% +$50.1K ﹤0.01% 1906
2024
Q3
$972K Sell
95,240
-15,149
-14% -$155K ﹤0.01% 1787
2024
Q2
$1.64M Buy
110,389
+16,629
+18% +$247K ﹤0.01% 1499
2024
Q1
$1.28M Buy
93,760
+13,967
+18% +$191K ﹤0.01% 1619
2023
Q4
$874K Sell
79,793
-19,340
-20% -$212K ﹤0.01% 1781
2023
Q3
$1.09M Buy
99,133
+351
+0.4% +$3.84K ﹤0.01% 1610
2023
Q2
$1.31M Buy
98,782
+14,333
+17% +$190K ﹤0.01% 1543
2023
Q1
$1.15M Buy
84,449
+20,857
+33% +$284K ﹤0.01% 1621
2022
Q4
$1.24M Buy
63,592
+3,636
+6% +$71K ﹤0.01% 1618
2022
Q3
$1.14M Buy
59,956
+4,845
+9% +$92.3K ﹤0.01% 1669
2022
Q2
$1.14M Buy
55,111
+10,591
+24% +$218K ﹤0.01% 1683
2022
Q1
$1.2M Buy
+44,520
New +$1.2M ﹤0.01% 1712